Company: RNAC
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001453687-25-000075
Chunk: 81

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 81
---
 following table provides information on our equity compensation plans as of December 31, 2024.

| Plan category                                                 |     | Number of securities    
 to be issued upon       
 exercise of outstanding 
 stock options, warrants 
 and rights              
 (a)                     |           |     |    |     | Weighted-average       
 exercise price of      
 outstanding options,   
 warrants and rights(1) 
 (b)                    |       |     |    |     | Number of securities    
 remaining available for 
 future issuance under   
 equity compensation     
 plans(2)                
 (c)                     |           |     |     |
|:--------------------------------------------------------------|:----|:------------------------|----------:|:----|---:|:----|:-----------------------|------:|:----|---:|:----|:------------------------|----------:|:----|----:|
| Equity compensation plans approved by security holders(3)     |     |                         |   912,419 |     | -4 |     | $                      | 19.66 |     | -5 |     |                         | 3,565,969 |     |  -6 |
| Equity compensation plans not approved by security holders(7) |     |                         | 1,237,854 |     | -8 |     | $                      |  8.03 |     | -9 |     |                         |   639,230 |     | -10 |
| Total                                                         |     |                         | 2,150,273 |     |    |     | $                      | 11.99 |     |    |     |                         | 4,205,199 |     |     |

(1) Represents the weighted-average exercise price of outstanding options and is calculated without taking into account outstanding RSUs.

(2) Pursuant to the terms of the 2016 Plan, the number of shares of Common Stock available for issuance under the 2016 Plan automatically increases on each January 1, until and including January 1, 2034, by an amount equal to the lesser of: (a) 4% of the number of shares of the Company’s Common Stock outstanding on the last day of the applicable preceding calendar year and (b) such smaller number of shares as is determined by our Board. Pursuant to the terms of the 2016 Employee Stock Purchase Plan (the “2016 ESPP”), the number of shares of Common Stock available for issuance under the 2016 ESPP automatically increases on